PMC:7195088 / 5758-6067 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"155","span":{"begin":133,"end":141},"obj":"Species"},{"id":"190","span":{"begin":113,"end":120},"obj":"Chemical"},{"id":"191","span":{"begin":221,"end":230},"obj":"Chemical"},{"id":"215","span":{"begin":124,"end":132},"obj":"Disease"}],"attributes":[{"id":"A155","pred":"tao:has_database_id","subj":"155","obj":"Tax:9606"},{"id":"A190","pred":"tao:has_database_id","subj":"190","obj":"MESH:C558899"},{"id":"A191","pred":"tao:has_database_id","subj":"191","obj":"MESH:D000069454"},{"id":"A215","pred":"tao:has_database_id","subj":"215","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ministered? At the present time, evidence from the first published RCT does not support off-label treatment with LPV/RTV in COVID-19 patients. This result should also discourage the use of other protease inhibitors (e.g. darunavir), at least until results of dedicated RCT are available. Although promising in"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T24","span":{"begin":124,"end":132},"obj":"Disease"}],"attributes":[{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ministered? At the present time, evidence from the first published RCT does not support off-label treatment with LPV/RTV in COVID-19 patients. This result should also discourage the use of other protease inhibitors (e.g. darunavir), at least until results of dedicated RCT are available. Although promising in"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T21","span":{"begin":92,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"ministered? At the present time, evidence from the first published RCT does not support off-label treatment with LPV/RTV in COVID-19 patients. This result should also discourage the use of other protease inhibitors (e.g. darunavir), at least until results of dedicated RCT are available. Although promising in"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T16","span":{"begin":92,"end":97},"obj":"Chemical"},{"id":"T17","span":{"begin":195,"end":214},"obj":"Chemical"},{"id":"T19","span":{"begin":204,"end":214},"obj":"Chemical"},{"id":"T20","span":{"begin":221,"end":230},"obj":"Chemical"}],"attributes":[{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A18","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_367163"}],"text":"ministered? At the present time, evidence from the first published RCT does not support off-label treatment with LPV/RTV in COVID-19 patients. This result should also discourage the use of other protease inhibitors (e.g. darunavir), at least until results of dedicated RCT are available. Although promising in"}

{"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":12,"end":142},"obj":"Sentence"},{"id":"T42","span":{"begin":143,"end":287},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ministered? At the present time, evidence from the first published RCT does not support off-label treatment with LPV/RTV in COVID-19 patients. This result should also discourage the use of other protease inhibitors (e.g. darunavir), at least until results of dedicated RCT are available. Although promising in"}